Townsend-Nicholson A, Baker E, Schofield PR, Sutherland GR (1995). „Localization of the adenosine A1 receptor subtype gene (ADORA1) to chromosome 1q32.1”. Genomics26 (2): 423–5. DOI:10.1016/0888-7543(95)80236-F. PMID7601478.
Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, Basheer R, Haas HL, Zilles K, Bauer A (2007). „Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study”. J. Neurosci.27 (9): 2410–5. DOI:10.1523/JNEUROSCI.5066-06.2007. PMID17329439.
Tawfik HE, Schnermann J, Oldenburg PJ, Mustafa SJ (2005). „Role of A1 adenosine receptors in regulation of vascular tone”. Am. J. Physiol. Heart Circ. Physiol.288 (3): H1411–6. DOI:10.1152/ajpheart.00684.2004. PMID15539423.
Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC (October 2007). „The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance”. Journal of the American College of Cardiology50 (16): 1551–60. DOI:10.1016/j.jacc.2007.07.019. PMID17936154.
Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM (October 2008). „The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment”. Journal of Cardiac Failure14 (8): 631–40. DOI:10.1016/j.cardfail.2008.08.010. PMID18926433.
nih.gov
ncbi.nlm.nih.gov
Townsend-Nicholson A, Baker E, Schofield PR, Sutherland GR (1995). „Localization of the adenosine A1 receptor subtype gene (ADORA1) to chromosome 1q32.1”. Genomics26 (2): 423–5. DOI:10.1016/0888-7543(95)80236-F. PMID7601478.
Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, Basheer R, Haas HL, Zilles K, Bauer A (2007). „Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study”. J. Neurosci.27 (9): 2410–5. DOI:10.1523/JNEUROSCI.5066-06.2007. PMID17329439.
Tawfik HE, Schnermann J, Oldenburg PJ, Mustafa SJ (2005). „Role of A1 adenosine receptors in regulation of vascular tone”. Am. J. Physiol. Heart Circ. Physiol.288 (3): H1411–6. DOI:10.1152/ajpheart.00684.2004. PMID15539423.
Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (December 2001). „International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors”. Pharmacol. Rev.53 (4): 527–52. PMID11734617.
Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC (October 2007). „The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance”. Journal of the American College of Cardiology50 (16): 1551–60. DOI:10.1016/j.jacc.2007.07.019. PMID17936154.
Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM (October 2008). „The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment”. Journal of Cardiac Failure14 (8): 631–40. DOI:10.1016/j.cardfail.2008.08.010. PMID18926433.